ADI-PEG20

Drug identity checked against registry records

Also recorded as Pegargiminase; pegargiminase

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular CarcinomaNCT05317819Polaris GroupPhase 3Recruiting2028-09Estimated
Study of ADI-PEG 20 Versus Placebo in Subjects With NASHNCT05842512Polaris GroupPhase 2Recruiting2027-12-31Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.